Source: Annual Congress 2011 - Experimental pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
X. Kqiku, G. Kovacs, E. Rohde, D. Strunk, H. Olschewski (Graz, Salzburg, Austria). Determination of cell-derived microparticles in patients with pulmonary hypertension and connective-tissue diseases using flow cytometry. Eur Respir J 2011; 38: Suppl. 55, 3345

Member's Comments

No comment yet.

Related content which might interest you: The flow cytometric immunophenotyping of peripheral blood in Chronic obstructive pulmonary disease patients Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019 Reduced spontaneous apoptosis in peripheral blood neutrophils during exacerbation of COPD Source: Eur Respir J 2004; 23: 532-537 Year: 2004 Increased regulatory T cells in the blood of patients with idiopathic pulmonary arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 659s Year: 2006 Pulmonary artery blood flow dynamics in patients with chronic thromboembolic pulmonary hypertension; Analysis by computational fluid dynamics Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension Year: 2019 Cellular microparticles in the pathogenesis of pulmonary hypertension Source: Eur Respir J 2013; 42: 272-279 Year: 2013 The inflammatory cell landscape in the lungs of patients with idiopathic pulmonary arterial hypertension Source: Eur Respir J, 51 (1) 1701214; 10.1183/13993003.01214-2017 Year: 2018 Apoptosis and activation of peripheral blood neutrophils in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 74s Year: 2001 Increased stimulatory capacities of dendritic cells in idiopathic pulmonary arterial hypertension Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010 Analysis of miRNA profile in circulating microparticles of patients with pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 Determination of pulmonary hypertension degree in patients with interstitial lung diseases Source: Annual Congress 2010 - Different patterns of interstitial lung disease Year: 2010 Circulating endothelial progenitor cells and chronic pulmonary diseases Source: Eur Respir J 2011; 37: 426 Year: 2011 Treprostinil inhibits the recruitment of bone marrow-derived circulating fibrocytes in chronic hypoxic pulmonary hypertension Source: Eur Respir J 2010; 36: 1302-1314 Year: 2010 LSC - 2020 - Comparison of metabolic profile in endothelial cells of chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020 Comparison of arterial and venous blood gases analysis in patients with exacerbation of chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 326s Year: 2007 Double combination therapy in patients with pulmonary arterial hypertension associated with connective tissue disease Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 Endothelial cell-derived microparticles as potential biomarkers in chronic interstitial lung diseases Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia Year: 2019 Circulating fibrocytes and pulmonary arterial hypertension Source: Eur Respir J 2011; 39: 210-212 Year: 2012 Circulating fibrocytes in pulmonary arterial hypertension Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension Year: 2011 Circulating fibrocytes and pulmonary arterial hypertension Source: Eur Respir J 2012; 39: 210-212 Year: 2012